BNP PARIBAS FINANCIAL MARKETS - CORBUS PHARMACEUTICALS HLDGS ownership

CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 113 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q4 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.0%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of CORBUS PHARMACEUTICALS HLDGS
ValueSharesWeighting
Q4 2022$11
-99.9%
1000.0%0.00%
Q3 2022$16,000
-36.0%
1000.0%0.00%
Q2 2022$25,000
-52.8%
1000.0%0.00%
Q1 2022$53,000
-72.3%
100
-67.8%
0.00%
Q4 2021$191,000
-94.2%
311
-90.4%
0.00%
Q3 2021$3,292,000
-51.2%
3,227
-12.4%
0.00%
Q2 2021$6,744,000
-67.3%
3,685
-64.8%
0.00%
Q1 2021$20,628,000
-77.0%
10,471
-85.4%
0.00%
Q4 2020$89,569,000
+154.4%
71,655
+266.3%
0.00%
Q3 2020$35,212,000
-41.1%
19,562
+174.4%
0.00%
Q2 2020$59,812,000
-40.2%
7,129
-62.6%
0.00%
Q1 2020$99,984,000
+155.9%
19,081
+166.6%
0.00%
Q4 2019$39,077,000
-13.0%
7,157
-22.4%
0.00%
Q3 2019$44,892,000
+3.1%
9,218
+46.8%
0.00%
Q2 2019$43,527,000
-46.4%
6,281
-46.2%
0.00%
Q1 2019$81,183,000
+87193.5%
11,681
+72906.2%
0.00%
Q4 2018$93,000
-99.2%
16
-98.9%
0.00%
Q3 2018$11,174,000
+49.5%
1,4800.0%0.00%
Q2 2018$7,474,000
-88.2%
1,480
-85.7%
0.00%
Q1 2018$63,330,000
-18.9%
10,382
-5.7%
0.00%
Q4 2017$78,128,000
+152.8%
11,004
+154.6%
0.00%
Q3 2017$30,902,000
+5.7%
4,322
-6.9%
0.00%
Q2 2017$29,245,0004,6420.00%
Other shareholders
CORBUS PHARMACEUTICALS HLDGS shareholders Q4 2020
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 5,045,870$1,273,0000.73%
ETF MANAGERS GROUP, LLC 7,062,485$1,787,0000.05%
Ikarian Capital, LLC 862,527$217,0000.04%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 457,209$115,0000.02%
Platform Technology Partners 33,750$9,0000.01%
PINNACLE ASSOCIATES LTD 910,006$230,0000.01%
CJM Wealth Advisers, Ltd. 30,465$7,6830.01%
Mirae Asset Global Investments Co., Ltd. 4,029,171$1,016,0000.00%
Vident Investment Advisory, LLC 267,612$67,0000.00%
Aries Wealth Management 15,400$4,0000.00%
View complete list of CORBUS PHARMACEUTICALS HLDGS shareholders